Correction: Chronic Morphine Treatment Attenuates Cell Growth of Human BT474 Breast Cancer Cells by Rearrangement of the ErbB Signalling Network.

Correction: Chronic Morphine Treatment Attenuates Cell Growth of Human BT474 Breast Cancer Cells by Rearrangement of the ErbB Signalling Network.

Show other versions (1)

Bibliographic Details
Main Authors:	Inka Regine Weingaertner, Sarah Koutnik, Hermann Ammer
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2015-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4599909?pdf=render

Similar Items

Correction: Chronic Morphine Treatment Attenuates Cell Growth of Human BT474 Breast Cancer Cells by Rearrangement of the ErbB Signalling Network.
by: Inka Regine Weingaertner, et al.
Published: (2016-01-01)

Chronic morphine treatment attenuates cell growth of human BT474 breast cancer cells by rearrangement of the ErbB signalling network.
by: Inka Regine Weingaertner, et al.
Published: (2013-01-01)

Modulation of ErbB2 blockade in ErbB2-positive cancers: the role of ErbB2 Mutations and PHLDA1.
by: Guangyuan Li, et al.
Published: (2014-01-01)

Betacellulin-induced beta cell proliferation and regeneration is mediated by activation of ErbB-1 and ErbB-2 receptors.
by: Yoon Sin Oh, et al.
Published: (2011-01-01)

Betacellulin-Induced α-Cell Proliferation Is Mediated by ErbB3 and ErbB4, and May Contribute to β-Cell Regeneration
by: Young-Sun Lee, et al.
Published: (2021-01-01)

Development and Characterization of Nanoliposomal Hydroxyurea Against BT-474 Breast Cancer Cells
by: Azam Akbari, et al.
Published: (2020-01-01)

Proliferation of colorectal cancer is promoted by two signaling transduction expression patterns: ErbB2/ErbB3/AKT and MET/ErbB3/MAPK.
by: Yong-Liang Yao, et al.
Published: (2013-01-01)

Role of ErbB receptors in cancer cell migration and invasion
by: Aline eAppert-Collin, et al.
Published: (2015-11-01)

Characterization of optical parameters of breast cancer cell line - BT474 by polarimetry technique
by: Thanh-Truc Nguyen, et al.
Published: (2022-03-01)

BT-474 Breast Cancer Cell Apoptosis Induced by Crocin, a Saffron Carotenoid
by: Nassim Faridi, et al.
Published: (2019-01-01)

Chromatin Modifications Sequentially Enhance ErbB2 Expression in ErbB2-Positive Breast Cancers
by: Sathish Kumar Mungamuri, et al.
Published: (2013-10-01)

ErbB1 and ErbB3 co-over expression as a prognostic factor in gastric cancer
by: Meysam Moghbeli, et al.
Published: (2019-01-01)

Photo-activated psoralen binds the ErbB2 catalytic kinase domain, blocking ErbB2 signaling and triggering tumor cell apoptosis.
by: Wenle Xia, et al.
Published: (2014-01-01)

Transcriptional profiling of ErbB signalling in mammary luminal epithelial cells - interplay of ErbB and IGF1 signalling through IGFBP3 regulation
by: Worthington Jenny, et al.
Published: (2010-09-01)

Quantitative modeling perspectives on the ErbB system of cell regulatory processes
by: Lazzara, Matthew J., et al.
Published: (2010)

Development of ErbB2-Targeting Liposomes for Enhancing Drug Delivery to ErbB2-Positive Breast Cancer
by: Sho Ueno, et al.
Published: (2020-06-01)

The role of protease activity in ErbB biology.
by: Blobel, C, et al.
Published: (2009)

Spinal nerve injury causes upregulation of ErbB2 and ErbB3 receptors in rat dorsal root ganglia
by: Mizobuchi S, et al.
Published: (2013-02-01)

Melatonin upregulates ErbB1 and ErbB4, two primary implantation receptors, in pre-implantation mouse embryos
by: Ghazaleh Moshkdanian, et al.
Published: (2017-06-01)

Valproic acid exhibits anti-tumor activity selectively against EGFR/ErbB2/ErbB3-coexpressing pancreatic cancer via induction of ErbB family members-targeting microRNAs
by: Tingting Lin, et al.
Published: (2019-04-01)

α-Mangostin and apigenin induced the necrotic death of BT474 breast cancer cells with autophagy and inflammation
by: Teeranai Ittiudomrak, et al.
Published: (2018-01-01)

BRAF mutant colorectal cancer: ErbB2 expression levels as predictive factor for the response to combined BRAF/ErbB inhibitors
by: Evelina Miele, et al.
Published: (2020-02-01)

ErbB- and MUC1-targetted CAR-T cell immunotherapy of oral squamous cell carcinoma
by: Saffron E. Summers, et al.
Published: (2023-03-01)

Computational modeling of ErbB kinase oligomeric state.
by: Lim, Sing Mei.
Published: (2010)

Proteolytic processing of ErbB4 in breast cancer.
by: Maija Hollmén, et al.
Published: (2012-01-01)

Blockade of ErbB2 and PD-L1 using a bispecific antibody to improve targeted anti-ErbB2 therapy
by: Deepak Mittal, et al.
Published: (2019-11-01)

Mammary cells with active Wnt signaling resist ErbB2-induced tumorigenesis.
by: Wen Bu, et al.
Published: (2013-01-01)

HER/ErbB receptor interactions and signaling patterns in human mammary epithelial cells
by: Chrisler William B, et al.
Published: (2009-10-01)

Generating a stable cell line of BT474-biosensor for tracking the metastasis of human breast cancer cells in animal models
by: Adhylakshumie Adhynarayanan
Published: (2011)

Combined inhibition of ErbB1/2 and Notch receptors effectively targets breast ductal carcinoma in situ (DCIS) stem/progenitor cell activity regardless of ErbB2 status.
by: Gillian Farnie, et al.
Published: (2013-01-01)

Exogenous HGF Bypasses the Effects of ErbB Inhibition on Tumor Cell Viability in Medulloblastoma Cell Lines.
by: Walderik W Zomerman, et al.
Published: (2015-01-01)

The Mysterious Ways of ErbB2/HER2 Trafficking
by: Vibeke Bertelsen, et al.
Published: (2014-08-01)

ErbB4 in the brain: Focus on high grade glioma
by: Jamie-Lee Pitcher, et al.
Published: (2022-08-01)

Role of C-erbB2 expression in gallbladder cancer
by: Niraj Kumari, et al.
Published: (2012-01-01)

Identification of nucleolin as new ErbB receptors- interacting protein.
by: Ayelet Di Segni, et al.
Published: (2008-01-01)

Structure-function analysis of nucleolin and ErbB receptors interactions.
by: Keren Farin, et al.
Published: (2009-01-01)

Treatment of ErbB2 breast cancer by mitochondrial targeting
by: Sophia Eldad, et al.
Published: (2020-07-01)

Topological analysis of MAPK cascade for kinetic ErbB signaling.
by: Takashi Nakakuki, et al.
Published: (2008-01-01)

Exploring the modulation of MLH1 and MSH2 gene expression in hesperetin-treated breast cancer cells (BT-474)
by: Ahmed Mohammed Salman, et al.
Published: (2024-01-01)

Human Blood Serum Inhibits Ductal Carcinoma Cells BT474 Growth and Modulates Effect of HER2 Inhibition
by: Dmitrii Kamashev, et al.
Published: (2022-08-01)